EPCAM and Cowden syndrome 1: The addition of solitomab to cultures of EpCAM expressing CS and autologous TAL appears to activate these tumor-anergic T cells in pleural fluid causing a cytotoxic T-cell response strong enough to eliminate resistant CS cells.